Is Health In Tech, Inc. Class A Common Stock (HIT) overvalued? · rev $19.5M
Health In Tech, Inc. Class A Common Stock (HIT) is a software - application company listed on US.
This page asks whether Health In Tech, Inc. Class A Common Stock (HIT) looks expensive on cached numbers — not a short thesis.
Latest reported HIT revenue for 2024-12-31 was $19.5M. Net income was $670.5K. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. HIT currently screens at market cap $63.2M.
HIT currently screens at market cap $63.2M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next HIT 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the HIT stock page for the full model, not this heading.
Not investment advice.